|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-2-7
|
|
pubmed:abstractText |
As SPECT/CT technology evolves, its applications and indications need to be evaluated clinically for more efficient and cost-effective use. This retrospective study evaluated the clinical value of simultaneously acquired (99m)Tc-sestamibi SPECT/CT versus conventional SPECT in diagnosing and locating parathyroid adenomas or hyperplasia in patients with primary hyperparathyroidism.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
248-52
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15695783-Adenoma,
pubmed-meshheading:15695783-Adult,
pubmed-meshheading:15695783-Aged,
pubmed-meshheading:15695783-Aged, 80 and over,
pubmed-meshheading:15695783-Diagnosis, Differential,
pubmed-meshheading:15695783-Female,
pubmed-meshheading:15695783-Humans,
pubmed-meshheading:15695783-Hyperparathyroidism,
pubmed-meshheading:15695783-Hyperplasia,
pubmed-meshheading:15695783-Image Enhancement,
pubmed-meshheading:15695783-Male,
pubmed-meshheading:15695783-Middle Aged,
pubmed-meshheading:15695783-Parathyroid Neoplasms,
pubmed-meshheading:15695783-Radiopharmaceuticals,
pubmed-meshheading:15695783-Reproducibility of Results,
pubmed-meshheading:15695783-Retrospective Studies,
pubmed-meshheading:15695783-Sensitivity and Specificity,
pubmed-meshheading:15695783-Subtraction Technique,
pubmed-meshheading:15695783-Technetium Tc 99m Sestamibi,
pubmed-meshheading:15695783-Tomography, Emission-Computed, Single-Photon,
pubmed-meshheading:15695783-Tomography, X-Ray Computed
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
|
|
pubmed:affiliation |
Department of Nuclear Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. igayed@di.mdacc.tmc.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Evaluation Studies,
Validation Studies
|
